BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Olema Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-04 7:49 pm Sale |
2024-12-04 | 13D | Olema Pharmaceuticals, Inc. OLMA |
BIOTECHNOLOGY VALUE FUND L P | 7,557,237 9.990% |
-1,578,656 (-17.28%) |
Filing |
| 2023-09-14 4:23 pm Purchase |
2023-09-12 | 13D | Olema Pharmaceuticals, Inc. OLMA |
BIOTECHNOLOGY VALUE FUND L P | 9,135,893 16.700% |
1,724,390 (+23.27%) |
Filing |
| 2021-12-02 5:05 pm Purchase |
2021-11-30 | 13D | Olema Pharmaceuticals, Inc. OLMA |
BIOTECHNOLOGY VALUE FUND L P | 7,411,503 18.400% |
750,000 (+11.26%) |
Filing |
| 2020-11-20 5:23 pm Purchase |
2020-11-19 | 13D | Olema Pharmaceuticals, Inc. OLMA |
BIOTECHNOLOGY VALUE FUND L P | 6,661,503 16.600% |
6,661,503 (New Position) |
Filing |